◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›NVS

NVS (NVS)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

GlobeNewswire·vor 2 Tagen

Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players

Zacks·vor 2 Tagen

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Zacks·vor 2 Tagen

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

GlobeNewswire·vor 3 Tagen

Atrial Fibrillation Market Trends and Forecast 2026-2035 Featuring Profiles of Abbott, Boston Scientific, Medtronic, Johnson & Johnson, Novartis, and Sanofi

MT Newswires·vor 4 Tagen

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

Stocktwits·vor 5 Tagen

IBRX Stock Extends 3-Day Slide — Founder Teases New Trial In ‘Unstoppable’ Cancer-Treatment Push

Frag BlackSpecter AI über NVS

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist NVS kaufenswert?NVS Earnings Analyse NVS Bewertung

AI Chat öffnen →